TY - JOUR
T1 - Deleterious coding variation associated with autism is shared across ancestries
AU - GALA Consortium
AU - The Autism Sequencing Consortium (ASC)
AU - Natividad Avila, Marina
AU - Jung, Seulgi
AU - Satterstrom, F. Kyle
AU - Fu, Jack M.
AU - Levy, Tess
AU - Sloofman, Laura G.
AU - Klei, Lambertus
AU - Pichardo, Thariana
AU - Marquez, Dalia
AU - Stevens, Christine R.
AU - Cusick, Caroline M.
AU - Ames, Jennifer L.
AU - Campos, Gabriele S.
AU - Cerros, Hilda
AU - Chaskel, Roberto
AU - Costa, Claudia I.S.
AU - Cuccaro, Michael L.
AU - Lopez, Andrea del Pilar
AU - Fernandez, Magdalena
AU - Ferro, Eugenio
AU - Galeano, Liliana
AU - Girardi, Ana Cristina D.E.S.
AU - Griswold, Anthony J.
AU - Hernandez, Luis C.
AU - Lourenço, Naila
AU - Ludena, Yunin
AU - Núñez-Ríos, Diana
AU - Oyama, Rosa
AU - Peña, Katherine P.
AU - Pessah, Isaac
AU - Schmidt, Rebecca
AU - Sweeney, Holly M.
AU - Tolentino, Lizbeth
AU - Wang, Jaqueline Y.T.
AU - Albores-Gallo, Lilia
AU - Croen, Lisa A.
AU - Cruz-Fuentes, Carlos S.
AU - Hertz-Picciotto, Irva
AU - Kolevzon, Alexander
AU - Lattig, Maria Claudia
AU - Mayo, Liliana
AU - Passos-Bueno, Maria Rita
AU - Pericak-Vance, Margaret A.
AU - Siper, Paige M.
AU - Tassone, Flora
AU - Trelles, M. Pilar
AU - Zweifach, Jessica
AU - Soufer, Renee
AU - Menashe, Idan
AU - Meiri, Gal
N1 - Publisher Copyright:
© The Author(s) 2026.
PY - 2026/4/1
Y1 - 2026/4/1
N2 - The past decade has seen remarkable progress in identifying genes that, when impacted by deleterious coding variation, confer high likelihood for autism spectrum disorder (ASD), intellectual disability and other associated developmental disorders. However, most underlying gene discovery efforts have focused on individuals of European ancestry, limiting insights into genetic liability across diverse populations. To help address this, the Genomics of Autism in Latin American Ancestries (GALA) Consortium was formed, presenting here the largest sequencing study of autism in Latin American individuals (n > 15,000, including 4,717 participants with an ASD diagnosis). We identified 35 genome-wide significant (false discovery rate < 0.05) autism-associated genes, with substantial overlap with findings from European cohorts, and highly constrained genes showing consistent signal across populations. The results provide support for emerging (for example, MARK2, YWHAG, PACS1, RERE, SPEN, GSE1, GLS, TNPO3 and ANKRD17) and established autism genes and for the utility of genetic testing approaches for deleterious variants in individuals from diverse backgrounds; the results also demonstrate the ongoing need for more inclusive genetic research and testing. We conclude that the biology of autism is consistent across populations, with no detectable influence of ancestry.
AB - The past decade has seen remarkable progress in identifying genes that, when impacted by deleterious coding variation, confer high likelihood for autism spectrum disorder (ASD), intellectual disability and other associated developmental disorders. However, most underlying gene discovery efforts have focused on individuals of European ancestry, limiting insights into genetic liability across diverse populations. To help address this, the Genomics of Autism in Latin American Ancestries (GALA) Consortium was formed, presenting here the largest sequencing study of autism in Latin American individuals (n > 15,000, including 4,717 participants with an ASD diagnosis). We identified 35 genome-wide significant (false discovery rate < 0.05) autism-associated genes, with substantial overlap with findings from European cohorts, and highly constrained genes showing consistent signal across populations. The results provide support for emerging (for example, MARK2, YWHAG, PACS1, RERE, SPEN, GSE1, GLS, TNPO3 and ANKRD17) and established autism genes and for the utility of genetic testing approaches for deleterious variants in individuals from diverse backgrounds; the results also demonstrate the ongoing need for more inclusive genetic research and testing. We conclude that the biology of autism is consistent across populations, with no detectable influence of ancestry.
UR - https://www.scopus.com/pages/publications/105035354837
U2 - 10.1038/s41591-026-04228-6
DO - 10.1038/s41591-026-04228-6
M3 - Article
C2 - 41912808
AN - SCOPUS:105035354837
SN - 1078-8956
VL - 32
SP - 1519
EP - 1529
JO - Nature Medicine
JF - Nature Medicine
IS - 4
ER -